Rescue, Combined, and Stand-Alone Thrombectomy in the Management of Large Vessel Occlusion Stroke Using the Solitaire Device: A Prospective 50-Patient Single-Center Study Timing, Safety, and Efficacy

被引:176
作者
Costalat, Vincent [1 ,3 ]
Machi, Paolo [1 ]
Lobotesis, Kyriakos [1 ]
Maldonado, Igor [1 ,2 ]
Vendrell, Jean Francois [1 ]
Riquelme, Carlos [1 ]
Mourand, Isabelle
Milhaud, Didier [2 ]
Heroum, Cherif [2 ]
Perrigault, Pierre-Francois [3 ]
Arquizan, Caroline [2 ]
Bonafe, Alain [1 ]
机构
[1] CHU Montpellier Neuroradiol, Montpellier, France
[2] CHU Montpellier Neurol, Montpellier, France
[3] CHU Montpellier, SARC, Montpellier, France
关键词
ischemic stroke; mechanical recanalization; reperfusion; self-expanding stent; thrombectomy; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; INTERVENTIONAL MANAGEMENT; INTRAVENOUS THROMBOLYSIS; ARTERY OCCLUSIONS; CEREBRAL-ISCHEMIA; CONTROLLED-TRIAL; EMBOLIC STROKE; THERAPY; REVASCULARIZATION;
D O I
10.1161/STROKEAHA.110.608976
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Large vessel occlusion in ischemic stroke is associated with a high degree of morbidity. When intravenous thrombolysis fails, mechanical thrombectomy can provide an alternative and synergistic method for flow restoration. In this study we evaluate the safety and efficacy of our stroke management protocol (RECOST study). Methods-Fifty consecutive ischemic stroke patients with large vessel occlusion were included. After clinical and MRI imaging assessment, 3 treatment strategies were selected according to time of symptom onset and location of vessel occlusion: rescue therapy; combined therapy; and stand-alone thrombectomy (RECOST study). MRI ASPECT score <5 was the main exclusion criterion. Mechanical thrombectomy was performed exclusively with the Solitaire flow restoration device. Clinical outcome was assessed after treatment, on day 1, and at discharge. Results-Mean patient age was 67.6 years, mean NIHSS score was 14.7, and mean ASPECT score was 6 on presentation. Vessel occlusions were in the middle cerebral artery (40%), the internal carotid artery (28%), and the basilar artery (32%). Rescue treatment represented 24%, combined therapy represented 56%, and stand-alone thrombectomy represented 20%. Mean recanalization time from symptoms onset was 377 minutes, with overall recanalization rate TICI 3 of 84%. NIHSS score at discharge was 6.5, with 60% of patients demonstrating NIHSS score 0 to 1 or an improvement of >9 points. Symptomatic complication rate was 10%. At 3 months, 54% of patients had a modififed Rankin scale score of 0 to 2, with an overall mortality rate of 12%. Conclusions-The present integrated stroke management protocol (RECOST study) demonstrated rapid, safe, and effective recanalization. We postulate that the Solitaire device contributed to high recanalization and patient selection using MRI ASPECT score to low and complication rates, therefore avoiding futile and dangerous interventions. (Stroke. 2011; 42: 1929-1935.)
引用
收藏
页码:1929 / 1935
页数:7
相关论文
共 32 条
[1]   Conscious Sedation Versus General Anesthesia During Endovascular Therapy for Acute Anterior Circulation Stroke Preliminary Results From a Retrospective, Multicenter Study [J].
Abou-Chebl, Alex ;
Lin, Ridwan ;
Hussain, Muhammad Shazam ;
Jovin, Tudor G. ;
Levy, Elad I. ;
Liebeskind, David S. ;
Yoo, Albert J. ;
Hsu, Daniel P. ;
Rymer, Marilyn M. ;
Tayal, Ashis H. ;
Zaidat, Osama O. ;
Natarajan, Sabareesh K. ;
Nogueira, Raul G. ;
Nanda, Ashish ;
Tian, Melissa ;
Hao, Qing ;
Kalia, Junaid S. ;
Nguyen, Thanh N. ;
Chen, Michael ;
Gupta, Rishi .
STROKE, 2010, 41 (06) :1175-1179
[2]   Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study [J].
Albers, Gregory W. ;
Thijs, Vincent N. ;
Wechsle, Lawrence ;
Kemp, Stephanie ;
Schlaug, Gottfried ;
Skalabrin, Elaine ;
Bammer, Roland ;
Kakuda, Wataru ;
Lansberg, Maarten G. ;
Shuaib, Ashfaq ;
Coplin, William ;
Hamilton, Scott ;
Moseley, Michael ;
Marks, Michael P. .
ANNALS OF NEUROLOGY, 2006, 60 (05) :508-517
[3]   Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy [J].
Barber, PA ;
Demchuk, AM ;
Zhang, JJ ;
Buchan, AM .
LANCET, 2000, 355 (9216) :1670-1674
[4]   Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial [J].
Bluhmki, Erich ;
Chamorro, Angel ;
Davalos, Antoni ;
Machnig, Thomas ;
Sauce, Christophe ;
Wahlgren, Nils ;
Wardlaw, Joanna ;
Hacke, Werner .
LANCET NEUROLOGY, 2009, 8 (12) :1095-1102
[5]   Mechanical thromboembolectomy for acute ischemic stroke: Comparison of the catch thromboectomy device and the Merci Retriever in vivo [J].
Brekenfeld, Caspar ;
Schroth, Gerhard ;
El-Koussy, Marwan ;
Nedeltchev, Krassen ;
Reinert, Michael ;
Slotboom, Johannes ;
Gralla, Jan .
STROKE, 2008, 39 (04) :1213-1219
[6]   The interventional management of stroke (IMS) II study [J].
Broderick, Joseph P. .
STROKE, 2007, 38 (07) :2127-2135
[7]   Mechanical Thrombectomy With the Solitaire AB Device in Large Artery Occlusions of the Anterior Circulation A Pilot Study [J].
Castano, Carlos ;
Dorado, Laura ;
Guerrero, Cristina ;
Millan, Monica ;
Gomis, Meritxell ;
Perez de la Ossa, Natalia ;
Castellanos, Mar ;
Rosa Garcia, M. ;
Domenech, Sira ;
Davalos, Antoni .
STROKE, 2010, 41 (08) :1836-1840
[8]   The ECASS III results and the tPA paradox [J].
Davis, Stephen ;
Donnan, Geoffrey .
INTERNATIONAL JOURNAL OF STROKE, 2009, 4 (01) :17-18
[9]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[10]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011